RxDoctor Payments Data

Britney Kneibert

Psychiatric/Mental Health · Creve Coeur, MONPI 1205599545

Payments from drug & device makers

$1,875in general payments, 2019–2025

Across 141 payments — averaging $13.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$528
  • Alkermes, Inc.$305
  • Teva Pharmaceuticals USA, Inc.$184
  • Sunovion Pharmaceuticals Inc.$130
  • Supernus Pharmaceuticals, Inc.$101
  • Johnson & Johnson$66
  • plus $561 from 15 others

What the payments were for

  • Food & beverage$1,875100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,875 in reported general payments places this provider in the 65th percentile of 565 psychiatric/mental health providers in Missouri.

See all psychiatric/mental health providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine12$49,138
Sertraline Hcl19$336
Lithium Carbonate20$320
Benztropine Mesylate19$243
Quetiapine Fumarate ErQuetiapine Fumarate12$147
Aripiprazole12$116
Gabapentin12$104

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$184$49,13812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 565 psychiatric/mental health providers in Missouri.

Other psychiatric/mental health in Creve Coeur

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →